Your browser doesn't support javascript.
loading
Survival analysis of carboplatin added to an anthracycline/taxane-based neoadjuvant chemotherapy and HRD score as predictor of response-final results from GeparSixto.
Loibl, S; Weber, K E; Timms, K M; Elkin, E P; Hahnen, E; Fasching, P A; Lederer, B; Denkert, C; Schneeweiss, A; Braun, S; Salat, C T; Rezai, M; Blohmer, J U; Zahm, D M; Jackisch, C; Gerber, B; Klare, P; Kümmel, S; Schem, C; Paepke, S; Schmutzler, R; Rhiem, K; Penn, S; Reid, J; Nekljudova, V; Hartman, A-R; von Minckwitz, G; Untch, M.
  • Loibl S; German Breast Group, Neu-Isenburg, Germany. Electronic address: sibylle.loibl@gbg.de.
  • Weber KE; German Breast Group, Neu-Isenburg, Germany.
  • Timms KM; Myriad Genetics Inc, Salt Lake City, USA.
  • Elkin EP; The Permanente Medical Group Inc, Oakland, USA.
  • Hahnen E; Center for Hereditary Breast and Ovarian Cancer, University Hospital Cologne, Cologne, Germany.
  • Fasching PA; Department of Gynecology and Obstetrics, University Hospital Erlangen, Erlangen, Germany.
  • Lederer B; German Breast Group, Neu-Isenburg, Germany.
  • Denkert C; Institute of Pathology, Charité University Hospital and German Cancer Consortium (DKTK), Berlin, Germany.
  • Schneeweiss A; National Center for Tumor Diseases, University Hospital Heidelberg, Heidelberg, Germany.
  • Braun S; Brustzentrum, Sana Kliniken Offenbach, Offenbach, Germany.
  • Salat CT; Hämatoonkologische Schwerpunktpraxis, Munich, Germany.
  • Rezai M; Luisenkrankenhaus, Düsseldorf, Germany.
  • Blohmer JU; Klinik für Gynäkologie mit Brustzentrum Charité, Berlin, Germany.
  • Zahm DM; Brustzentrum SRH Waldklinikum, Gera, Germany.
  • Jackisch C; Brustzentrum, Sana Kliniken Offenbach, Offenbach, Germany.
  • Gerber B; Frauenklinik, Universität Rostock, Rostock, Germany.
  • Klare P; Praxisklinik, Berlin, Germany.
  • Kümmel S; Breast Unit, Kliniken Essen-Mitte, Essen, Germany.
  • Schem C; Mammazentrum am Krankenhaus Jerusalem, Hamburg, Germany.
  • Paepke S; Klinikum rechts der Isar der Technischen Universität München, Frauenklinik, München, Germany.
  • Schmutzler R; Center for Hereditary Breast and Ovarian Cancer, University Hospital Cologne, Cologne, Germany.
  • Rhiem K; Center for Hereditary Breast and Ovarian Cancer, University Hospital Cologne, Cologne, Germany.
  • Penn S; Myriad Genetics Inc, Salt Lake City, USA.
  • Reid J; Myriad Genetics Inc, Salt Lake City, USA.
  • Nekljudova V; German Breast Group, Neu-Isenburg, Germany.
  • Hartman AR; GRAIL, Menlo Park, USA.
  • von Minckwitz G; German Breast Group, Neu-Isenburg, Germany.
  • Untch M; Helios-Klinikum Berlin-Buch, Berlin, Germany.
Ann Oncol ; 29(12): 2341-2347, 2018 12 01.
Article en En | MEDLINE | ID: mdl-30335131
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Carboplatino / Reparación del ADN por Recombinación / Neoplasias de la Mama Triple Negativas Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Año: 2018 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Carboplatino / Reparación del ADN por Recombinación / Neoplasias de la Mama Triple Negativas Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Año: 2018 Tipo del documento: Article